You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 54 No. 3, March 1997 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ORIGINAL ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (199)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

The Course of Psychopathologic Features in Mild to Moderate Alzheimer Disease

D. P. Devanand, MD; Diane M. Jacobs, PhD; Ming-Xin Tang, PhD; Caridad Del Castillo-Castaneda; Mary Sano, PhD; Karen Marder, MD; Karen Bell, MD; Frederick W. Bylsma, PhD; Jason Brandt, PhD; Marilyn Albert, PhD; Yaakov Stern, PhD

Arch Gen Psychiatry. 1997;54(3):257-263.


Abstract



Background
The onset and course of the psychopathologic features of Alzheimer disease have not been established in prospective, longitudinal studies.

Methods
Two hundred thirty-five patients with early, probable Alzheimer disease were recruited at 3 sites and observed naturalistically for up to 5 years. At 6-month intervals, the Columbia University Scale for Psychopathology in Alzheimer's Disease was administered. Markov analyses were used to predict the probability of a specific symptom developing or being maintained at the next visit. For each symptom category, the maximum frequency of occurrence at 4 consecutive points (duration, 2 years) was calculated.

Results
Misidentification, wandering or agitation, and physical aggression increased during follow-up. At any visit, the likelihood of a new symptom developing was greatest for behavioral disturbance, intermediate for paranoid delusions and hallucinations, and least for depressed mood with vegetative features. Wandering or agitation occurred at 3 or more of 4 consecutive visits (duration, 2 years) in the majority of patients, paranoid delusions and hallucinations were intermediate in their degree of persistence, and depressed mood with vegetative signs rarely persisted.

Conclusions
Behavioral disturbance, particularly agitation, is common and persistent in patients with Alzheimer disease. Psychotic symptoms are less common and show moderate persistence over time. Depressed mood with vegetative signs is uncommon and rarely persists. These findings suggest leads about the optimal treatment duration for specific subtypes of psychopathologic features.



Author Affiliations



From the Memory Disorders Clinic in the New York State Psychiatric Institute, the Center for Alzheimer's Disease Research in New York City, and the Departments of Psychiatry (Drs Devanand and Stern) and Neurology (Drs Jacobs, Tang, Sano, Marder, Bell, and Stern and Ms Del Castillo-Castaneda) and the Gertrude H. Sergievsky Center (Drs Jacobs, Tang, Sano, Marder, Bell, Stern, and Ms Del Castillo-Castaneda), College of Physicians and Surgeons of Columbia University, New York, NY; the Department of Psychiatry and Behavioral Sciences, The Johns Hopkins University, Baltimore, Md (Drs Bylsma and Brandt); and the Departments of Psychiatry and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston (Dr Albert).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Chronic Divalproex Sodium to Attenuate Agitation and Clinical Progression of Alzheimer Disease
Tariot et al.
Arch Gen Psychiatry 2011;68:853-861.
ABSTRACT | FULL TEXT  

Review: Risk of Cerebrovascular Adverse Events and Death in Elderly Patients With Dementia When Treated With Antipsychotic Medications: A Literature Review of Evidence
Mittal et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2011;26:10-28.
ABSTRACT  

Stress and Burden Among Caregivers of Patients with Lewy Body Dementia
Leggett et al.
The Gerontologist 2011;51:76-85.
ABSTRACT | FULL TEXT  

The Relation of Patient Dependence to Home Health Aide Use in Alzheimer's Disease
Scherer et al.
J Gerontol A Biol Sci Med Sci 2008;63:1005-1009.
ABSTRACT | FULL TEXT  

Effect of Bright Light and Melatonin on Cognitive and Noncognitive Function in Elderly Residents of Group Care Facilities: A Randomized Controlled Trial
Riemersma-van der Lek et al.
JAMA 2008;299:2642-2655.
ABSTRACT | FULL TEXT  

Disruptive Behavior as a Predictor in Alzheimer Disease
Scarmeas et al.
Arch Neurol 2007;64:1755-1761.
ABSTRACT | FULL TEXT  

Treatment of Cognitive Decline and Psychiatric Disturbances Associated With Alzheimer's Dementia
Blaszczyk and Mathys
Journal of Pharmacy Practice 2007;20:13-28.
ABSTRACT  

The progression of cognition, psychiatric symptoms, and functional abilities in dementia with lewy bodies and Alzheimer disease.
Stavitsky et al.
Arch Neurol 2006;63:1450-1456.
ABSTRACT | FULL TEXT  

Longitudinal study of effects of patient characteristics on direct costs in Alzheimer disease
Zhu et al.
Neurology 2006;67:998-1005.
ABSTRACT | FULL TEXT  

Switching Elderly Patients With Dementia From Risperidone to Quetiapine: A Retrospective Study
Madhusoodanan and Bogunovic
AM J ALZHEIMERS DIS OTHER DEMEN 2006;21:169-174.
ABSTRACT  

Delusions and Hallucinations Are Associated With Worse Outcome in Alzheimer Disease
Scarmeas et al.
Arch Neurol 2005;62:1601-1608.
ABSTRACT | FULL TEXT  

Longitudinal Study on the Relationship Between Symptomatology of Dementia and Levels of Subjective Burden and Depression Among Family Caregivers in Memory Clinic Patients
Berger et al.
J Geriatr Psychiatry Neurol 2005;18:119-128.
ABSTRACT  

Psychosis in Elderly Patients: Classification and Pharmacotherapy
Mintzer and Targum
J Geriatr Psychiatry Neurol 2003;16:199-206.
ABSTRACT  

Neuropsychiatric Symptoms in Latino Elders With Dementia or Cognitive Impairment Without Dementia and Factors That Modify Their Association With Caregiver Depression
Hinton et al.
The Gerontologist 2003;43:669-677.
ABSTRACT | FULL TEXT  

Treating Depression in Alzheimer Disease: Efficacy and Safety of Sertraline Therapy, and the Benefits of Depression Reduction: The DIADS
Lyketsos et al.
Arch Gen Psychiatry 2003;60:737-746.
ABSTRACT | FULL TEXT  

Comorbidity of Psychopathological Domains in Community-Dwelling Persons with Alzheimer's Disease
Tractenberg et al.
J Geriatr Psychiatry Neurol 2003;16:94-99.
ABSTRACT  

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Petrella et al.
Radiology 2003;226:315-336.
ABSTRACT | FULL TEXT  

Drugs for disruptive features in dementia
DTB 2003;41:1-4.
ABSTRACT | FULL TEXT  

Managing behavioural and psychological symptoms in dementia
LAWLOR
Br. J. Psychiatry 2002;181:463-465.
FULL TEXT  

Depression and Alzheimer's disease: Symptom or comorbidity?
Moretti et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2002;17:338-344.
ABSTRACT  

Emergent Psychopathology in Alzheimer's Disease Patients Over 12 Months Associated with Functional, Not Cognitive, Changes
Tractenberg et al.
J Geriatr Psychiatry Neurol 2002;15:110-117.
ABSTRACT  

Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease
Scarmeas et al.
Neurology 2002;58:1182-1188.
ABSTRACT | FULL TEXT  

Apolipoprotein E and Alpha-1-Antichymotrypsin Genotypes Do Not Predict Time to Psychosis in Alzheimer's Disease
Sweet et al.
J Geriatr Psychiatry Neurol 2002;15:24-30.
ABSTRACT  

Increased familial risk of the psychotic phenotype of Alzheimer disease
Sweet et al.
Neurology 2002;58:907-911.
ABSTRACT | FULL TEXT  

Antecedents, descriptions and consequences of wandering in cognitively-impaired adults and the Safe Return (SR) program
Rowe and Glover
AM J ALZHEIMERS DIS OTHER DEMEN 2001;16:344-352.
ABSTRACT  

Measuring Alzheimer's disease progression with transition probabilities: Estimates from CERAD
Neumann et al.
Neurology 2001;57:957-964.
ABSTRACT | FULL TEXT  

The 5-HTTPR*S/*L Polymorphism and Aggressive Behavior in Alzheimer Disease
Sukonick et al.
Arch Neurol 2001;58:1425-1428.
ABSTRACT | FULL TEXT  

Hallucinations, delusions, and cognitive decline in Alzheimer's disease
Wilson et al.
J. Neurol. Neurosurg. Psychiatry 2000;69:172-177.
ABSTRACT | FULL TEXT  

Incidence of and risk factors for hallucinations and delusions in patients with probable AD
Paulsen et al.
Neurology 2000;54:1965-1971.
ABSTRACT | FULL TEXT  

Changes in emotional and behavioral symptoms of Alzheimer's disease
Lee et al.
AM J ALZHEIMERS DIS OTHER DEMEN 2000;15:176-179.
ABSTRACT  

Psychiatric Medication and Abnormal Behavior as Predictors of Progression in Probable Alzheimer Disease
Lopez et al.
Arch Neurol 1999;56:1266-1272.
ABSTRACT | FULL TEXT  

Characteristics of Sleep Disturbance in Community-Dwelling Alzheimer's Disease Patients
McCurry et al.
J Geriatr Psychiatry Neurol 1999;12:53-59.
ABSTRACT  

Dopamine Receptor Genetic Variation, Psychosis, and Aggression in Alzheimer Disease
Sweet et al.
Arch Neurol 1998;55:1335-1340.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.